Advances in systemic juvenile idiopathic arthritis associated-lung disease
10.3760/cma.j.cn101070-20220531-00642
- VernacularTitle:全身型幼年特发性关节炎相关肺部病变研究进展
- Author:
Wenjie XUAN
1
;
Meiping LU
Author Information
1. 浙江大学医学院附属儿童医院风湿免疫变态反应科，杭州 310003
- Keywords:
Systemic juvenile idiopathic arthritis;
Lung disease;
Macrophage activation syndrome;
Biologics;
Biomarker;
Treatment;
Prognosis
- From:
Chinese Journal of Applied Clinical Pediatrics
2023;38(8):615-618
- CountryChina
- Language:Chinese
-
Abstract:
Systemic juvenile idiopathic arthritis(sJIA) is one of the most serious critical illnesses in childhood, characterized by high fever, recurrent rash, and arthritis, etc.Children with sJIA associated-lung disease(sJIA-LD) are more severely ill and have a worse prognosis, the correlation between the mechanism and age, disease activity, anti-rheumatic drug therapy, applications of biologics, infection and other factors is worth exploring.This article reviews the research progress on the mechanism, risk factors, treatment methods and prognosis of sJIA-LD, so as to provide a theoretical basis for improving the diagnosis and treatment of sJIA and improving the prognosis.
